Mechanisms and consequences of Jak-STAT signaling in the immune system
By A. Villarino, Y. Kanno, J. O’Shea. Nature Immunology, 2017
1,064 citations recorded by the source corpus.
Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system. Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clinical insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs. Here we review recent advances in Jak–STAT biology, focusing on immune cell function, disease etiology and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/35f2127dea650e8635b7e27aa102e0525dd22088
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Xia Zhao
- Maorong Fu
- Jing Li
- Wei Wang
- Xiaoying Hu
Citations in the corpus
- The JAK/STAT signaling pathway: from bench to clinic (2021, background): “More cytokine/receptor antibodies are being studied, such as anti-IL-4, anti-IL-4R, anti-IL-5R, anti-IL-6R, anti-IL-9, and anti-IL-13.(6)”